• Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • Maternova is a mission-driven corporation focused on women and newborn health.


    Our social enterprise has impacted over 2.1 million lives since 2015.

    2.1 million

    Women and Infants

    180+

    Countries

    30.000

    Clinicians

    30

    SME partners

    Thumbnail for Maternova video, includes women, children and doctors

    Problems We Focus On

    STIs and HIV: Women and Children

    Embark on a Path of Hope: Maternova's Lifesaving Solutions for Women and Children

    Learn more

    Women's Reproductive Health

    Experience the Cutting-Edge Bouquet Speculum:
    Advancing Women's Reproductive Well-being.

    Learn more

    As seen in ...

    Cartier Women's Initiative Awards Logo

    Work with us

    Listen to our customers

    Our Trusted Partners

    logo-1
    logo-2
    logo-3
    logo-4
    logo-5
    logo-6
    logo-7
    logo-8
    logo-9
    The bubble CPAP reducing neonatal mortality by 27 percent

    The bubble CPAP reducing neonatal mortality by 27 percent

    2 min read

    NIgerian experience with a pilot in 7 hospitals using the bubble CPAP.
    DreamWarming, infant warming mattress, infant transport mattress, infant hypothermia solution

    An innovation in the warm chain: The DreamWarmer

    2 min read

    The warming mattress (made up of strips of phase change material) can stay warm for 6 or more hours.  It is a flexible mattress that can be used in conjunction with skin to skin contact or with Kangaroo Mother Care.
    antenatal corticosteroids expert advice from FIGO

    Antenatal corticosteroids: FIGO states they should not be given “just in case”

    2 min read

    According to the American College of Obstetricians and Gynecologists (ACOG) and the International Federation of Gynecology and Obstetrics (FIGO), the administration of antenatal corticosteroids is recommended in women with a pregnancy between 24 and 34 weeks who are at risk of preterm birth within the next seven days.